RPG Life Sciences rises on receiving nod to sell, transfer its Biotech Unit to Intas Pharmaceuticals

27 May 2016 Evaluate

RPG Life Sciences is currently trading at Rs. 262.40, up by 8.55 points or 3.37% from its previous closing of Rs. 253.85 on the BSE.

The scrip opened at Rs. 260.00 and has touched a high and low of Rs. 265.00 and Rs. 260.00 respectively. So far 7,058 shares were traded on the counter.

The BSE group 'B ' stock of face value Rs. 8 has touched a 52 week high of Rs. 360.60 on 03-Dec-2015 and a 52 week low of Rs. 138.00 on 24-Aug-2015.

Last one week high and low of the scrip stood at Rs. 265.00 and Rs. 250.10 respectively. The current market cap of the company is Rs. 434.07 crore.

The promoters holding in the company stood at 66.79% while Institutions and Non-Institutions held 0.29% and 32.92% respectively.

RPG Life Sciences (RPGLS), part of the RPG Group, engaged in manufacturing and marketing of pharmaceutical products, has received an approval for the sale and transfer of its Biotech Unit, as a going concern on a slump sale basis to Intas Pharmaceuticals. The board of directors at its meeting held on May 26, 2016 has approved for the same.

RPG Life Sciences is an integrated pharmaceutical company operating in the domestic and international markets in the Branded Formulations, Global Generics, Synthetic and Fermentation APIs space. The company is a research based, pharmaceutical company, producing a wide range of quality, affordable medicines. Its brands are highly trusted by healthcare professionals and patients.


RPG Life Sciences Share Price

2306.70 -65.55 (-2.76%)
16-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.80
Dr. Reddys Lab 1279.00
Cipla 1500.00
Zydus Lifesciences 913.90
Lupin 2089.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×